Zoekresultaten - 223 results
Hepatitis E virus in pork meat products and exposure assessment in Belgium.
Publication Type: Peer reviewed scientific article Authors: Locus, Tatjana; Lambrecht, Ellen; Peeters, Michael; Vanessa Suin; Verhaegen, Bavo; Van Hoorde, Koenraad; Lamoral, Sophie; Vanwolleghem, ...
Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants.
a mutation such as E119V- NA is known, highly sensitive PCR-based genotypic assays can be used to identify the prevalence of such mutant influenza viruses in clinical samples. In this study, based on an ...
A Multifaceted Approach for Evaluating Hepatitis E Virus Infectivity In Vitro: Cell Culture and Innovative Molecular Methods for Integrity Assessment
Veterinary Sciences, Volume 10, Issue 12 (2023) Health Topics: Food-borne illness Voedseltoxi-infecties (toxi-)infection alimentaire (TIA) Health and disease monitoring Surveillance de la santé et des ...
Genomic monitoring of SARS‐CoV‐2 variants using sentinel SARI hospital surveillance
Bourgeois, Marc; Delaere, Bénédicte; Magerman, Koen; Jouck, Door; Lissoir, Bénédicte; Sion, Catherine; Reynders, Marijke; Petit, Evelyn; Dauby, Nicolas; Hainaut, Marc; Laenen, Lies; Maes, Piet; Baele, Guy; ...
Development of Digital Droplet PCR Targeting the Influenza H3N2 Oseltamivir-Resistant E119V Mutation and Its Performance through the Use of Reverse Genetics Mutants
https://sciensano.be/en/10.3390/cimb45030165 File: Version: Published Full text access: Public Access Full text language: English Category: Peer-reviewed scientific articles FOS Classification: 3.03 Health sciences ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
(0.56-0.74)), in particular in patients 40 years and older (e.g. treatment within 48 hours: 40-59 years aOR 0.43, 95% CI: 0.28-0.66; 60-79 years 0.50 (0.39-0.63); ≥80 years 0.51 (0.42-0.63)).ConclusionNAI ...
Epidemiologische surveillance van rabiës- 2022
Publication Type: Sci. report, recommendat°, guidance doc., directive, monograph Authors: Javiera Rebolledo; Stefani, Giulietta; S. Leen; Inne Nauwelaers; Sanne Terryn Source: Sciensano, Brussels, ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
IgG of the reduced dose regimen (1,705 BAU /mL) was not non-inferior to the full dose regimen (2,387 BAU /mL), with a GMR of 0.714 (two-sided 95% CI 0.540–0.944). No serious adverse events occurred. ...
Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.
primary endpoint. RESULTS: We included 56 individuals, of whom 52 completed the study. The one-year boostability was 90% (47/52) with a GMT of 6.16 (95% CI 3.83-9.91). All participants seroconverted at some point in ...
Continued Circulation of Tick-Borne Encephalitis Virus Variants and Detection of Novel Transmission Foci, the Netherlands.
Publication Type: Peer reviewed scientific article Authors: Helen J Esser; Stephanie M Lim; de Vries, Ankje; Sprong, Hein; Dinant J Dekker; Emily L Pascoe; Julian W Bakker; Vanessa Suin; Franz, ...